Niravam FDA Approval History
FDA Approved: Yes (Discontinued) (First approved January 19, 2005)
Brand name: Niravam
Generic name: alprazolam
Dosage form: Orally Disintegrating Tablets
Company: UCB, Inc.
Treatment for: Anxiety, Panic Disorder
Marketing Status: Discontinued
Niravam (alprazolam) is an orally disintegrating benzodiazepine indicated for the short-term relief of anxiety and panic attacks.
Development timeline for Niravam
|Jan 19, 2005||Approval Niravam Schwarz Pharma AG - Treatment for Anxiety Disorders|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.